1. Home
  2. ORRF vs DBVT Comparison

ORRF vs DBVT Comparison

Compare ORRF & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orrstown Financial Services Inc

ORRF

Orrstown Financial Services Inc

HOLD

Current Price

$41.89

Market Cap

791.0M

Sector

Finance

ML Signal

HOLD

Logo DBV Technologies S.A.

DBVT

DBV Technologies S.A.

HOLD

Current Price

$12.44

Market Cap

850.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORRF
DBVT
Founded
1919
2002
Country
United States
France
Employees
N/A
90
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
791.0M
850.9M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
ORRF
DBVT
Price
$41.89
$12.44
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$42.00
$32.04
AVG Volume (30 Days)
63.9K
269.8K
Earning Date
04-21-2026
05-12-2026
Dividend Yield
3.29%
N/A
EPS Growth
182.43
10.26
EPS
2.21
N/A
Revenue
$37,144,000.00
$5,636,000.00
Revenue This Year
N/A
$35.04
Revenue Next Year
$3.15
$2,360.78
P/E Ratio
$18.94
N/A
Revenue Growth
36.00
35.77
52 Week Low
$31.88
$8.86
52 Week High
$43.81
$26.19

Technical Indicators

Market Signals
Indicator
ORRF
DBVT
Relative Strength Index (RSI) 46.32 40.13
Support Level $40.97 N/A
Resistance Level $42.78 $14.90
Average True Range (ATR) 0.87 0.53
MACD -0.06 -0.10
Stochastic Oscillator 38.68 27.91

Price Performance

Historical Comparison
ORRF
DBVT

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: